2023

January

· The company’s project, “Construction and Application of a Modern Research Model for Tibetan Medicines Guided by Tibetan Medical Theory,” has been awarded the Second Prize for Science and Technology by the Tibet Autonomous Region.

February

· The company was awarded the “Specialized, Fine, and New” SME Honor by the Informationization Department of the Tibet Autonomous Region for the 2022-2024 period.

· The subsidiary, Gansu Foge Tibetan Medicine Co., Ltd., has been awarded the honorary title of “Top Ten Outstanding Chain Leader Units in Lin Tao County’s Advantageous Industrial Chains.”

March

· The company was awarded the “Engineering and Technology Talent Contribution Award” by the 3rd China International Science Exchange Foundation.

April

· Qizheng® Pain Relief Plaster was awarded the title of “2022 China Over-the-Counter Drug Golden Product” by the China Association of Non-prescription Drugs.

· Ms. Lei Jufang, Chairperson of the company, has been awarded the “Outstanding Contribution Award for Tibetan Medicine in the Tibet Autonomous Region”;

· The company’s Bai Mai Ointment production team was awarded the title of “Pioneer Worker Team” by the All-China Federation of Trade Unions of the Tibet Autonomous Region.

· Qizheng® Pain-Relieving Plaster was awarded the honor of “Influential Brand in the Pharmaceutical Industry” at the 17th China Consumer Economy High-Level Forum.

· The company was awarded the A-level tax credit rating for 2022;

May

· The “2022 Annual Engineering Technology Research Center for Secondary Development of Tibetan Medicines of Tibet Tibetan Medicine Group Co., Ltd.,” established by its subsidiary Tibet Tibetan Medicine Group Co., Ltd., has officially been awarded a plaque by the Science and Technology Bureau of Lhasa City.

· The company has been awarded the “14th Tianma Award – New Media Award for Investor Relations”;

· The company was listed on the “2022 Panoramic Investor Relations Gold Award” list and received the “Best Interaction with Small and Medium-Sized Investors Award” and the “Best New Media Operations Award.”

· The subsidiary, Tibet Tibetan Medicine Group Co., Ltd., has been jointly recognized by the Ministry of Agriculture and Rural Affairs, the National Development and Reform Commission, the Ministry of Commerce, the People's Bank of China, the China Securities Regulatory Commission, and the All-China Federation of Supply and Marketing Cooperatives as a “National Key Leading Enterprise for Industrialization.”

· The subsidiaries Tibet Qizheng Tibetan Medicine Marketing Co., Ltd., Gansu Qizheng Tibetan Medicine Co., Ltd., and Gansu Qizheng Tibetan Medicine Marketing Co., Ltd. were each awarded the A-level tax credit rating for the year 2022.

June

· The company was listed on Minitrend’s “2022 Top 100 Chinese Traditional Chinese Medicine Enterprises Ranking,” placing 29th.

· Qizheng® Pain Relief Plaster has been listed on the “2023 China Pharmaceutical Brand Ranking” (retail terminals) by Minenet.

August

· The company brand Qizheng® ranked 41st on the “2023 Health Industry Brand Value List” released by the China Health Industry Summit, with a brand value of 2.87 billion yuan.

September

· The company’s patent “A Tibetan Medicine for Treating Women’s Diseases and Its Preparation Method” has been awarded the “Third Prize for Patents of Gansu Province”;

· The company’s research papers, “HPLC Fingerprint and Quality Control Study of Artemisia scoparia,” and “HPLC Fingerprint Study of Tibetan Medicinal Plant Salix babylonica and Determination of Isoquercitrin Content,” were awarded the “Outstanding Paper” prize at the 2023 Academic Symposium on Ethnic Medicines within the Drug Inspection System and the Outstanding Paper Exchange Meeting.

· The company was recognized by the Department of Economy and Information Technology of the Tibet Autonomous Region as a “Key Enterprise for Digital Transformation in the Tibet Autonomous Region for 2022”;

· The company was awarded the honorary title of “Typical Employer Promoting Employment of Persons with Disabilities” by Linzhi City.

October

· The company was listed at No. 12 on the “Top 20 Chinese Medicine Enterprises with the Greatest International Influence” list released by the SCO Traditional Medicine Industry Conference and the International Life & Health Industry Cooperation Conference.

· The company’s case was selected as a “Best Practice Case in Corporate Governance 2023” by the China Association of Listed Companies and included in the “China Listed Companies Governance Report.”

· The subsidiary Gansu Qizheng Tibetan Medicine Co., Ltd. has been recognized as a “National High-Tech Enterprise”;

November

· The subsidiary, Tibet Tibetan Medicine Group Co., Ltd., has been recognized by the Lhasa Municipal Bureau of Economy and Information Technology as a “Innovative Small and Medium-sized Enterprise in Lhasa.”

December

· The company has been recognized as a “High-Tech Enterprise” by the state;

· The company case “Responsibility Drives Sustainable Development” won the Silver Award in the “Corporate ESG Practice Innovation” category at the 2023 ECI FESTIVAL International Digital Innovation Festival.

· The company was listed on the “2023 Top 100 Chinese Patent Medicine Manufacturers” list by the China Association of Traditional Chinese Medicine, ranking 54th.

· The company ranked 29th in the “2023 Comprehensive Statistical Ranking of Chinese Over-the-Counter Drug Manufacturers” released by the China Association of Non-Prescription Drugs.

· Qizheng® Pain Relief Plaster, Qizheng® Xigaiwang® Iron Hammer Pain Relief Ointment, and Zhuopanlin® Ten-Flavor Gentian Flower Granules have been included in the “2022-2023 China Household Essential Medicines List of Top Brands”;

· Qizheng® Pain Relief Plaster was awarded the title of “2023 China Over-the-Counter Drug Golden Best-Selling Product” by the China Association of Non-Prescription Drugs.

· The company has been awarded the title of “Demonstration Enterprise for Building Harmonious Labor Relations in Linzhi City”;

· The subsidiary, Gansu Qizheng Tibetan Medicine Co., Ltd., was awarded the title of “Outstanding Health Enterprise” for 2023 by Lanzhou City.

· The company was selected for the All-China Federation of Industry and Commerce’s “Outstanding Cases of Social Responsibility of Chinese Private Enterprises (2023)”;

· The company was listed on the “Top 100 Best Corporate Responsibility Brands” in the 7th CSR China Education Ranking.

· The company has been awarded the “Three-Star Volunteer Service Enterprise” by the You Ai You Wei Lai Public Welfare Promotion Center.

· The subsidiary, Tibet Tibetan Medicine Group Co., Ltd., has been recognized as a “Specialized, Fine, and New Small and Medium-sized Enterprise of the Tibet Autonomous Region for 2023.”